A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
The Brighterside of News on MSN
New study finds 40Hz sensory stimulation may benefit some Alzheimer’s patients for years
A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...
An underdog Alzheimer's pill, ALZ-801, showed promise in a subgroup of mild cognitive impairment patients, slowing decline by ...
"This extraordinary gift represents remarkable generosity and the Cardinal Family's belief in our shared goal of funding research that will lead to therapeutic solutions and, one day, a cure for ...
The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...
12don MSN
Solano County man sees success slowing onset of Alzheimer's decline thanks to new treatment
Ahead of Solano County's Walk to End Alzheimer's Saturday morning in Fairfield, one Rio Vista man reflects on how the meaning ...
The Haunt for the Cure haunted house in Paynesville, MN, is scaring up donations to fight Alzheimer’s. Founded by Chelsea ...
WELLESLEY HILLS, Mass., Sept. 9, 2025 /PRNewswire/ -- Cure Alzheimer's Fund announces that Natasha Hussain, Ph.D., has been named Executive Vice President, Research Management, for the nonprofit ...
Largest donation in the non-profit organization's 20-year history WELLESLEY HILLS, Mass., Sept. 26, 2025 /PRNewswire/ -- Today, Cure Alzheimer's Fund (CureAlz) announced it has received a $50 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results